Fat tissue could explain triple negative breast cancer spread—and point to treatments
· Medical Xpressedited by Gaby Clark, reviewed by Robert Egan
Gaby Clark
Scientific Editor
Meet our editorial team
Behind our editorial process
Robert Egan
Associate Editor
Meet our editorial team
Behind our editorial process Editors' notes
This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
fact-checked
peer-reviewed publication
trusted source
proofread
The GIST Add as preferred source
Triple-negative breast cancer (TNBC) is aggressive and hard to treat. But the role of fat tissue in how the cancer spreads may help point toward new understanding and treatments, according to a new paper from scientists at the Hackensack Meridian Center for Discovery and Innovation (CDI) and colleagues at Georgetown University's Lombardi Comprehensive Cancer Center.
The scientists have now demonstrated that fat tissue can be hijacked by tumor cells to help them spread further inside the body using adipomes, which are minuscule extracellular vesicles released by fat tissue that spread from the breast to other organs.
This discovery may provide a new strategy for preventing disease progression at much earlier stages than currently possible. The findings appear in npj Breast Cancer published by senior author Jyothi Nagajyothi, Ph.D., a member of the Center for Discovery and Innovation (CDI) and Georgetown Lombardi, and lead author Hariprasad Thangavel, Ph.D., a member of Nagajyothi's research team. The study was conducted in collaboration with Georgetown Lombardi's Robert Glazer, Ph.D., professor of oncology at Georgetown University, and other investigators from the research team.
"The findings of this study establish adipomes as potent and previously unrecognized regulators of the metastatic cascade in TNBC," the authors write.
"This work challenges the traditional view of tumor-adjacent adipocytes as passive lipid reservoirs and instead reveals their active and dynamic role as key orchestrators of the mammary TME (tumor microenvironment)," they add.
What was previously known is that the "metastatic cascade" begins with cancer cells invading the stroma, the supportive tissue and blood vessels in the breast, enabled by invadopodia, which are kind of like tentacles of proteins protruding from the plasma membrane that degrade the body's defenses and pave the way for cancer's spread. That process has been well observed by scientists.
Nagajyothi's team has now probed the earlier phases leading to that process, focusing especially on adipomes, which are kind of like cellular messengers that kick off the cancer growth cycle. Using human clinical samples acquired from the Hackensack Meridian Health (HMH) Network Biorepository and preclinical models, they scrutinized each step of the process.
To do this, the team pioneered a first-of-its-kind purification technique capable of isolating pure adipomes from intact tissues, blood and other bodily fluids—a major technical hurdle that had previously blocked progress in the field. This unique method is so distinct that it is currently the subject of a pending U.S. patent application (US Patent App. 19/233,485) filed by Hackensack Meridian Health. Both Nagajyothi and Thangavel are named as inventors.
The adipomes deliver a specific "lipid code" that reprograms the cancer cells, activating stress-response signaling, boosting protein synthesis and upregulating key processes including mitochondrial signaling and translational machinery between cells. All of this comes together to foster invadopodia in TNBC.
But there could be future therapies interrupting this process, in turn possibly turning the tide against this tough tumor type, the scientists write.
"Together, these findings establish adipocyte-derived adipomes as potent regulators of TNBC invasion and metastasis and reveal a previously unrecognized tumor-adipocyte signaling axis that may present new opportunities for therapeutic targeting," they conclude.
Publication details
Hariprasad Thangavel et al, Cancer-associated adipomes promote invadopodia formation and enhance metastatic potential in triple-negative breast cancer, npj Breast Cancer (2026). DOI: 10.1038/s41523-026-00985-2
Journal information: npj Breast Cancer
Key medical concepts
Triple Negative Breast NeoplasmsExtracellular VesiclesNeoplasm Metastasis
Clinical categories
Oncology Provided by Hackensack Meridian Health Who's behind this story?
Gaby Clark
MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →
Robert Egan
Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →
Citation: Fat tissue could explain triple negative breast cancer spread—and point to treatments (2026, June 23) retrieved 23 June 2026 from https://medicalxpress.com/news/2026-06-fat-tissue-triple-negative-breast.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.